Aktie A096530 SEEGENE, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Seegene, Inc.

Aktien

A096530

KR7096530001

A096530

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
22’150 KRW -0.67% Intraday Chart für Seegene, Inc. +1.14% -3.28%
14.03. Seegene, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
24.01. Seegene Inc. kündigt Zusammenarbeit mit Microsoft an, um eine Welt frei von allen Krankheiten zu verwirklichen CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Seegene and UK Health Security Agency convene a summit to collectively realize 'a World Free from All Diseases'
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"
Seegene and Springer Nature Announce Awardees for the Open Innovation Program
Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'
Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases
Seegene obtains ISO45001 certification
Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy; Expanded Collaboration Aims To Improve Syndromic Infectious Disease Testing
Microbix Brief: Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on July 13, 2023.
Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on February 28, 2023.
Seegene, Inc.'s Equity Buyback announced on February 28, 2023, has expired with 2,046,354 shares, representing 4.11% for KRW 49,998.4 million.
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Seegene Inc. Unveils Solutions to Popularize Molecular Diagnostics At 2023 AACC
Seegene, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.
Seegene, Inc. authorizes a Buyback Plan.
Seegene, Inc. and Werfen Partner to Collaborate on Onesystem Business to Develop Syndromic qPCR Assays
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A096530 Aktie
  4. Nachrichten Seegene, Inc.
  5. Andere Sprachen